10.1126/science.1112915 84 MokraD.MokryJ
Leverage our advanced R&D and custom formulations to reduce development costs, accelerate time-to-market, and cultivate lasting consumer loyalty with products proven to revitalize scalps, stimulate growth, and strengthen roots
Food and Drug Administration guidelines and the Drug Supply Chain Security Act
Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data
DAVE FOUNDERS: Paras Chitrakar, Jason Wilk (CEO), John Wolanin EQUITY RAISED: $13 million ESTIMATED 2018 REVENUE: $19 million LEAD INVESTORS: Mark Cuban, Section 32 As a college student at Loyola Marymount University, Jason Wilk, now 34, blew through his budget, collecting overdraft fees